Skip to content
drillr.ai
Sign up

GLSI

Greenwich LifeSciences, Inc.

NASDAQ · Healthcare · Biotechnology · US

$15.95
+2.05%
Ask drillr

  • Aug 10, 2026, 10:00 UTC

    Greenwich LifeSciences' Board of Directors extended the lock-up of shares held by its directors, officers, and pre-IPO investors to January 31, 2027, restricting their sale of common stock until that date.

    Source:

  • Jul 22, 2026, 10:00 UTC

    Greenwich LifeSciences received regulatory approval to expand its Phase III clinical trial FLAMINGO-01 into the United Kingdom.

    Source: